Assessment and management of heart failure in patients with chronic kidney disease

Area of Science:

• Cardiology
• Nephrology
• Pharmacology

Background:

• Heart failure (HF) and chronic kidney disease (CKD) are highly prevalent and interconnected conditions.
• Their coexistence necessitates multidisciplinary and personalized patient management.
• Advances in HF treatment pose challenges for managing comorbid CKD, particularly regarding drug safety.

Purpose of the Study:

• To provide insights into the diagnostic assessment of coexisting HF and CKD.
• To offer guidance on the therapeutic management of patients with both HF and CKD.
• To clarify safe drug administration guidelines based on renal function.

Main Methods:

• Review of current literature on HF and CKD diagnosis and management.
• Analysis of diagnostic tools including clinical signs, symptoms, biomarkers, and imaging.
• Examination of pharmacological treatments for HF in the context of varying renal clearance.

Main Results:

• Diagnosis relies on clinical evaluation supplemented by biomarkers and imaging.
• Safe HF drug administration in CKD patients is complex and requires careful consideration of renal function.
• Understanding creatinine and renal clearance thresholds is crucial for safe medication dosing.

Conclusions:

• Integrated management is essential for patients with concurrent HF and CKD.
• Accurate assessment of renal function is critical for optimizing HF pharmacotherapy.
• Further research is needed to refine guidelines for managing these complex comorbidities.